Subham Dutta

Subham Dutta

Active Director Director DIN 03049914
DIN 03049914 First appointment Jun 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Jun 2010
Shareholding value •••• Premium profile

About Subham Dutta

Data last updated:

Subham Dutta is a Director at Syncorp Health Private Limited (since 2019), Director at Koin Lifesciences Private Limited (since 2020) and Director at Syn Corp Clincare Technologies Private Limited (since 2010), and holds 1 more current directorship. The companies operate in Pharma, Chemicals and Business Services. The 3 current companies with reported revenue have a combined latest revenue of ₹3.15 Cr; the largest is Syncorp Health Private Limited at ₹2.94 Cr (FY 2024). Earlier, Subham Dutta was a Director at Clinsol Consultancy Private Limited (2017–2023).

DIN 03049914
Primary Designation Director
Industry Pharma
First Appointment 28 Jun 2010
Oldest Company Age 16 yrs
Largest company Syncorp Health Private Limited · ₹2.94 Cr (FY 2024)
Combined revenue ₹3.15 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Syncorp Health Private Limited U73100KA2019PTC120119
Director08 Jan 20192019₹2.94 Cr (FY 2024)Active
Koin Lifesciences Private Limited U24239KA2020PTC133617
Director31 Mar 20202020₹15.7 Lakh (FY 2025)Active
Director28 Jun 20102010₹4.8 Lakh (FY 2024)Active
Digiceutical India Private Limited U74999KA2020PTC137892
Director29 Aug 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Clinsol Consultancy Private Limited U73200KA2017PTC101317
Director14 Mar 20172017₹56 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Koin Lifesciences Private Limited
Syncorp Health Private Limited
Syn Corp Clincare Technologies Private Limited
Digiceutical India Private Limited
Premium access

Shareholding and investment profile for Subham Dutta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subham Dutta

Subham Dutta currently holds 4 directorships: Syncorp Health Private Limited (Director, since 08 Jan 2019, revenue ₹2.94 Cr (FY 2024)); Koin Lifesciences Private Limited (Director, since 31 Mar 2020, revenue ₹15.7 Lakh (FY 2025)); Syn Corp Clincare Technologies Private Limited (Director, since 28 Jun 2010, revenue ₹4.8 Lakh (FY 2024)); Digiceutical India Private Limited (Director, since 29 Aug 2020).

Subham Dutta was first appointed on 28 Jun 2010 as Director at Syn Corp Clincare Technologies Private Limited. The most recent appointment on record is 29 Aug 2020 at Digiceutical India Private Limited.

The 3 current companies of Subham Dutta that report revenue have a combined latest revenue of ₹3.15 Cr: Syncorp Health Private Limited ₹2.94 Cr (FY 2024); Koin Lifesciences Private Limited ₹15.7 Lakh (FY 2025); Syn Corp Clincare Technologies Private Limited ₹4.8 Lakh (FY 2024).

Subham Dutta held 1 earlier board appointment: Clinsol Consultancy Private Limited (Director, 14 Mar 2017 to 15 Nov 2023).

The current boards of Subham Dutta's companies include Deepak Hanume Gowda (Syncorp Health Private Limited), Vedha Gowda (Syncorp Health Private Limited), Arabinda Patnaik (Koin Lifesciences Private Limited), Kanipakam Srinivas (Koin Lifesciences Private Limited), Banadhahali Sowmya Channappa (Syn Corp Clincare Technologies Private Limited), Bangalore Ravindra Krishnappa (Syn Corp Clincare Technologies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available